Bank Of America Corp Adc Therapeutics Sa Transaction History

Bank Of America Corp

$1.33 Trillion
Q2 2025

A detailed history of Bank Of America Corp transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Bank Of America Corp holds 2,199,059 shares of ADCT stock, worth $6.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,199,059

Previous 1,801,154 22.09%

Holding current value

$6.47 Million

Previous $2.54 Million 132.1%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.1 - $3.67 $437,695 - $1.46 Million	397,905 Added 22.09%	2,199,059 $5.89 Million
Q1 2025 May 15, 2025	BUY	$1.39 - $2.02 $708,774 - $1.03 Million	509,910 Added 39.49%	1,801,154 $2.54 Million
Q4 2024 Feb 14, 2025	SELL	$1.89 - $3.48 $2.28 Million - $4.2 Million	-1,206,696 Reduced 48.31%	1,291,244 $2.57 Million
Q3 2024 Nov 14, 2024	BUY	$2.59 - $4.01 $3.32 Million - $5.14 Million	1,281,522 Added 105.35%	2,497,940 $7.87 Million
Q2 2024 Aug 14, 2024	BUY	$2.55 - $5.09 $57,556 - $114,886	22,571 Added 1.89%	1,216,418 $3.84 Million
Q1 2024 May 15, 2024	SELL	$1.66 - $5.29 $550,944 - $1.76 Million	-331,894 Reduced 21.75%	1,193,847 $5.36 Million
Q4 2023 Feb 14, 2024	SELL	$0.47 - $1.79 $66,256 - $252,338	-140,971 Reduced 8.46%	1,525,741 $2.53 Million
Q2 2023 Aug 14, 2023	BUY	$1.9 - $2.66 $41,617 - $58,264	21,904 Added 1.33%	1,666,712 $3.58 Million
Q1 2023 May 12, 2023	BUY	$1.92 - $5.45 $77,149 - $218,991	40,182 Added 2.5%	1,644,808 $3.21 Million
Q4 2022 Feb 10, 2023	BUY	$2.87 - $5.24 $4.59 Million - $8.37 Million	1,597,765 Added 23287.64%	1,604,626 $6.16 Million
Q3 2022 Nov 14, 2022	BUY	$4.66 - $10.31 $2,418 - $5,350	519 Added 8.18%	6,861 $33,000
Q2 2022 Aug 12, 2022	SELL	$5.96 - $14.99 $7,551 - $18,992	-1,267 Reduced 16.65%	6,342 $50,000
Q1 2022 May 16, 2022	SELL	$13.28 - $20.03 $1.24 Million - $1.87 Million	-93,268 Reduced 92.46%	7,609 $112,000
Q4 2021 Feb 08, 2022	BUY	$19.29 - $31.51 $1.79 Million - $2.92 Million	92,621 Added 1121.86%	100,877 $2.04 Million
Q3 2021 Nov 15, 2021	SELL	$20.45 - $30.0 $33,333 - $48,900	-1,630 Reduced 16.49%	8,256 $225,000
Q2 2021 Sep 13, 2021	BUY	$20.38 - $27.04 $201,476 - $267,317	9,886 New	9,886 $240,000

Others Institutions Holding ADCT

# of Institutions

Shares Held

67.9M

Call Options Held

68.2K

Put Options Held

75.8K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $228M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Adc Therapeutics Sa Transaction History